• SENSEX 77,219.65
    301.80 (+0.39%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,824.90 1,878.00(%)
  • Reliance Industries
    1,318.95 1,611.20(%)
  • Bharti Airtel
    2,042.90 1,726.05(%)
  • SBI Life Insuran
    1,706.80 2,132.90(%)
  • Saregama India
    647.20 574.85(%)
  • Aster DM Quality
    728.05 890.95(%)
  • Multi Comm. Exc.
    3,252.50 1,761.43(%)
  • Jio Platforms
    1,420.50 1,356.40(%)
  • Shree Cement
    24,342.85 28,306.45(%)
  • SFC Enviro.
    397.60 354.05(%)
  • HDFC Bank
    741.00 1,017.90(%)
  • Global Health
    1,422.10 1,542.00(%)
  • BLS Polymers
    257.50 225.00(%)
  • Info Edg.(India)
    1,159.40 909.20(%)
  • J K Cements
    5,048.20 4,670.05(%)
  • ITC
    283.50 421.70(%)
  • SBI
    987.75 1,234.80(%)
  • M & M
    2,948.55 3,840.00(%)
  • Fractal Analyt.
    844.40 1,119.60(%)
  • TBO Tek
    1,522.00 1,005.50(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Bal Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4704.0
  • ISIN : INE083D01012
81.80 1 (1.23%)
  • As on 04 Nov 2026 (EOD)

  • Today’s Low

    81.10

  • Today’s High

    84.45

  • Open

    83.60

  • Perv Close

    80.81

  • 52W Low

    60.00

  • 52W High

    124.60

Key Indicators

  • P/E(TTM)

    17.23

  • Mar.Cap (₹Cr.)

    130.23

  • Div & Yield %

    1.46

  • Book Value(₹)

    65.39

  • Debt-Equity Ratio

    1.23

  • AGM Date

    03-Nov-2026

  • EPS

    4.77

  • P/E Ratio

    17.23

Financials Ratios

  • Debt-Equity Ratio

    1.99

  • Mar.Cap (₹Cr.)

    130.23

  • RONW (%)

    10.97

  • ROCE (%)

    11.29

Score Board

  • Equity (₹ in Cr.)

    15.92

  • BV (₹)

    65.40

  • Sales( ₹ in Cr.)

    310.80

  • NP (in Cr.)

    6.70

  • NP Var(%)

    -14.0

  • Div%

    12.0

  • CPS (₹)

    11.20

  • EPS (₹)

    4.20

  • Traded Value (₹ in Lakhs)

    130.87

  • 52 Week High

    124.60

  • 52 Week Low

    60.00

  • Price BSE

    82.0

  • Price NSE

    82.00

  • Market Capital( in Cr.)

    130.87

  • P/C Ratio

    7.40

  • P/E Ratio

    19.50

  • Price Vs.BV

    4.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 310.80 302.50 338.54 303.10 280.37 249.31
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 310.80 302.50 338.54 303.10 280.37 249.31
Other Income 2.00 2.15 2.30 2.19 6.49 2.69
Stock Adjustments 12.25 7.08 1.06 17.90 4.85 -5.13
Total Income 325.05 311.73 341.90 323.19 291.71 246.87
EXPENDITURE :            
Raw Materials 170.10 164.85 192.80 187.83 171.35 145.45
Power and Fuel Cost 9.59 8.29 8.73 6.87 5.37 4.70
Employee Cost 65.92 61.83 59.57 51.56 44.46 39.62
Other Manufacturing Expenses 13.04 10.90 12.95 20.20 14.64 9.12
Selling and Administration Expenses 29.68 33.01 32.27 26.21 21.64 15.44
Miscellaneous Expenses 2.28 0.42 1.56 1.90 4.35 3.24
Employee Benefit Expenses 65.92 61.83 59.57 51.56 44.46 39.62
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 290.61 279.30 307.89 294.56 261.82 217.57
Operating Profit 34.44 32.42 34.01 28.62 29.89 29.30
Interest 17.02 17.04 14.64 12.59 10.60 12.25
Gross Profit 17.42 15.38 19.37 16.03 19.29 17.05
Depreciation 11.06 9.65 10.05 7.48 7.24 7.26
Profit Before Tax 6.36 5.73 9.32 8.55 12.05 9.79
Current Tax 0.00 -0.14 0.76 2.03 5.42 0.38
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.39 -1.93 0.84 0.39 -1.94 0.32
Reported Net Profit 6.75 7.80 7.73 6.13 8.58 9.10
Extraordinary Items 0.06 0.00 0.05 0.03 0.78 0.04
Adjusted Net Profit 6.69 7.80 7.68 6.10 7.80 9.06
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 48.74 42.90 36.74 42.37 35.27 26.18
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.91 1.96 1.57 1.56 1.48 0.00
P & L Balance carried down 53.58 48.74 42.90 46.94 42.37 35.27
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 12.00 12.00 12.00 10.00 10.00 10.00
Dividend Per Share(Rs) 1.20 1.20 1.20 1.00 1.00 1.00
Earnings Per Share-Unit Curr 4.24 4.90 4.89 3.90 5.79 6.14
Earnings Per Share(Adj)-Unit Curr 4.24 4.90 4.89 3.90 5.79 6.14
Book Value 65.39 62.07 58.74 61.21 58.28 52.88
Book Value(Adj)-Unit Curr 65.39 62.07 58.74 61.21 58.28 52.88

Shareholding Pattern

  • Promoter Group

    50.86%

  • Public Share Holding

    49.14%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 655,187 655,187.00 655,187 655,187
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 655,187 4.12 655,187 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,011,736 12.64 2,011,736 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,430,259 34.11 5,430,259 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,441,995 46.74 7,441,995 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 43,794 0.28 43,794 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 43,794 0.28 43,794 3
2] Non Institution
Bodies Corporate 97,572 0.61 97,471 50
Clearing Members 13,314 0.08 13,314 8
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 100 0.00 0 1
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,798,565 11.30 1,794,065 153
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 398,582 2.50 398,582 277
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,605,770 10.09 1,605,770 23
Individuals holding nominal share capital up to Rs. 1 lakh 3,724,073 23.39 3,645,631 14,712
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 141,719 0.89 141,719 1
Sub Total 7,779,896 48.87 7,696,753 15,227
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 15,920,872 100.00 15,837,729 15,241

Company Background

Bal Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Bal Pharma Ltd
  • BSE Code : 4704.0
  • ISIN : INE083D01012

  • Incorporation Year

    1987

  • Registered Office

    21 & 22 Bommasandra Indl Area
    Hosur Road, Bangalore,
    Karnataka-560092

  • Telephone

  • FAX

  • Chairman

  • Managing Director

    Shailesh Siroya

  • Company Secretary

    Abdul Basith

  • Auditor

    SSJNB & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Bal Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Bal Pharma 82.20 312.80 310.80 17.23 8.99
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77